Literature DB >> 33553691

The heptamer sgRNA targeting the human OCT4 mRNA can upregulate the OCT4 expression.

Tadasuke Nozaki1, Masayuki Takahashi2, Tatsuya Ishikawa2, Arisa Haino2, Mineaki Seki2, Hidetomo Kikuchi1, Bo Yuan1, Masayuki Nashimoto2.   

Abstract

TRUE gene silencing is one of the gene suppression technologies. This technology exploits the enzymatic property of the tRNA 3' processing endoribonuclease tRNase ZL, which is that it can cleave a target RNA under the direction of a small guide RNA (sgRNA). We have been working on the development of therapeutic sgRNAs for hematological malignancies. In the course of an experiment to examine the ability of the heptamer-type sgRNA H15792 targeting the OCT4 mRNA to differentiate human amnion stem cells, we observed unexpectedly that the amnion cells exhibited a morphology resembling initialized cells. Here we investigated the effect of H15792 on human HL60 leukemia cells, and found that H15792 can upregulate the OCT4 expression and the expression of alkaline phosphatase in the cells.
© 2021 The Authors.

Entities:  

Keywords:  Amnion cell; HL60; OCT4; TRUE gene Silencing; sgRNA

Year:  2021        PMID: 33553691      PMCID: PMC7859166          DOI: 10.1016/j.bbrep.2021.100918

Source DB:  PubMed          Journal:  Biochem Biophys Rep        ISSN: 2405-5808


  34 in total

1.  A novel 4-base-recognizing RNA cutter that can remove the single 3' terminal nucleotides from RNA molecules.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-06-28       Impact factor: 16.971

2.  Gene silencing by the tRNA maturase tRNase ZL under the direction of small-guide RNA.

Authors:  A Nakashima; H Takaku; H S Shibata; Y Negishi; M Takagi; M Tamura; M Nashimoto
Journal:  Gene Ther       Date:  2006-08-03       Impact factor: 5.250

3.  Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNA.

Authors:  Norihiro Watanabe; Miwako Narita; Akie Yamahira; Tomoyo Taniguchi; Tatsuo Furukawa; Tetsuo Yoshida; Tatsuya Miyazawa; Masayuki Nashimoto; Masuhiro Takahashi
Journal:  Leuk Res       Date:  2013-02-10       Impact factor: 3.156

4.  Specific cleavage of target RNAs from HIV-1 with 5' half tRNA by mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto
Journal:  RNA       Date:  1996-06       Impact factor: 4.942

5.  A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

Review 6.  Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease.

Authors:  Sümeyye Elgaz; Zyrafete Kuçi; Selim Kuçi; Halvard Bönig; Peter Bader
Journal:  Transfus Med Hemother       Date:  2019-02-04       Impact factor: 3.747

7.  Suppression of apoptotic cell death progressed in vitro with incubation of the chorion laeve tissues of human fetal membrane by glucocorticoid.

Authors:  K Ohyama; K Oka; A Emura; H Tamura; T Suga; T Bessho; S Hirakawa; T Yamakawa
Journal:  Biol Pharm Bull       Date:  1998-10       Impact factor: 2.233

8.  Inhibition of vascular endothelial growth factor expression by TRUE gene silencing.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Masato Tamura; Masayuki Nashimoto
Journal:  Biochem Biophys Res Commun       Date:  2009-01-09       Impact factor: 3.575

9.  Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease.

Authors:  E Ilker Ozay; Jyothi Vijayaraghavan; Gabriela Gonzalez-Perez; Sudarvili Shanthalingam; Heather L Sherman; Daniel T Garrigan; Karthik Chandiran; Joe A Torres; Barbara A Osborne; Gregory N Tew; Igor I Slukvin; Ross A Macdonald; Kilian Kelly; Lisa M Minter
Journal:  Stem Cell Res       Date:  2019-02-01       Impact factor: 2.020

10.  Potential physiological roles of the 31/32-nucleotide Y4-RNA fragment in human plasma.

Authors:  Sho Ninomiya; Tatsuya Ishikawa; Masayuki Takahashi; Mineaki Seki; Masayuki Nashimoto
Journal:  Noncoding RNA Res       Date:  2019-11-22
View more
  1 in total

Review 1.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.